Laparoscopic device developer Xenocor said today it won CE Mark approval in the European Union for its single-use Xeonoscope laparoscopic systems.
The Salt Lake City, Utah-based company touted the device as the 1st single-use laparoscope offered in a sterile condition.
The device is now indicated for use in diagnostic and therapeutic procedures for endoscopy and endoscopic surgery within the thoracic and peritoneal cavities, including the female reproductive organs.
“We are committed to advancing the state-of-the-art and providing exceptional value to clinicians and hospitals alike by bringing effective diagnostic laparoscopy modalities to world-wide markets. This clearance allows us to bring products to world-wide markets with superior imaging characteristics including new design characteristics such as pre-white balanced illumination designed to eliminate the need for intra-operative adjustments while reducing the cost of care,” CEO Ashok Khandkar said in prepared remarks.
The Xenoscope system eliminates the need for cleaning and disinfection of the scope between cases, the company said, which can reduce the cost of sterilization service contracts.